{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T00:52:45Z","timestamp":1794185565939,"version":"4.8.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1RO1AG058660-01"],"award-info":[{"award-number":["1RO1AG058660-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87921-9","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T05:03:54Z","timestamp":1739163834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Sigma-2 receptor modulator CT1812 alters key pathways and rescues retinal pigment epithelium (RPE) functional deficits associated with dry age-related macular degeneration (AMD)"],"prefix":"10.1038","volume":"15","author":[{"given":"Britney N.","family":"Lizama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunah","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evi M.","family":"Malagise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Knezovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora","family":"Waybright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Watto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Look","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Di Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony O.","family":"Caggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Arjuna","family":"Ratnayaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Hamby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"87921_CR1","unstructured":"Liste, S. Blindness and vision impairment. World Health Organ.. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment (2022)."},{"key":"87921_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Heal. 2, e106\u2013e116 (2014).","journal-title":"Lancet Glob Heal"},{"key":"87921_CR3","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.clinthera.2021.08.011","volume":"43","author":"NM Schultz","year":"2021","unstructured":"Schultz, N. M., Bhardwaj, S., Barclay, C., Gaspar, L. & Schwartz, J. Global Burden of Dry Age-Related Macular Degeneration: a targeted literature review. Clin. Ther. 43, 1792\u20131818 (2021).","journal-title":"Clin. Ther."},{"key":"87921_CR4","doi-asserted-by":"publisher","first-page":"e10422","DOI":"10.1097\/MD.0000000000010422","volume":"97","author":"Y Wei","year":"2018","unstructured":"Wei, Y., Liao, H. & Ye, J. Therapeutic effects of various therapeutic strategies on non-exudative age-related macular degeneration. Med. (Baltim). 97, e10422 (2018).","journal-title":"Med. (Baltim)."},{"key":"87921_CR5","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","volume":"402","author":"JS Heier","year":"2023","unstructured":"Heier, J. S. et al. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet 402, 1434\u20131448 (2023).","journal-title":"Lancet"},{"key":"87921_CR6","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","volume":"402","author":"AM Khanani","year":"2023","unstructured":"Khanani, A. M. et al. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet 402, 1449\u20131458 (2023).","journal-title":"Lancet"},{"key":"87921_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche, L. G. et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat. Genet. 48, 134\u2013143 (2016).","journal-title":"Nat. Genet."},{"key":"87921_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/hmg\/ddy002","volume":"27","author":"Q Yan","year":"2018","unstructured":"Yan, Q. et al. Genome-wide analysis of disease progression in age-related macular degeneration. Hum. Mol. Genet. 27, 929\u2013940 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"87921_CR9","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41588-019-0351-9","volume":"51","author":"R Ratnapriya","year":"2019","unstructured":"Ratnapriya, R. et al. Retinal transcriptome and eQTL analyses identify genes associated with age-related macular degeneration. Nat. Genet. 51, 606\u2013610 (2019).","journal-title":"Nat. Genet."},{"key":"87921_CR10","doi-asserted-by":"publisher","first-page":"20753","DOI":"10.1038\/s41598-022-24537-3","volume":"12","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. \u03c32R\/TMEM97 in retinal ganglion cell degeneration. Sci. Rep. 12, 20753 (2022).","journal-title":"Sci. Rep."},{"key":"87921_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0039-6257(05)80092-X","volume":"39","author":"AC Bird","year":"1995","unstructured":"Bird, A. C. et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv. Ophthalmol. 39, 367\u2013374 (1995).","journal-title":"Surv. Ophthalmol."},{"key":"87921_CR12","doi-asserted-by":"publisher","first-page":"e111898","DOI":"10.1371\/journal.pone.0111898","volume":"9","author":"NJ Izzo","year":"2014","unstructured":"Izzo, N. J. et al. Alzheimer\u2019s therapeutics targeting amyloid Beta 1\u201342 oligomers I: Abeta 42 Oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits. PLoS One. 9, e111898 (2014).","journal-title":"PLoS One"},{"key":"87921_CR13","doi-asserted-by":"publisher","first-page":"e111899","DOI":"10.1371\/journal.pone.0111899","volume":"9","author":"NJ Izzo","year":"2014","unstructured":"Izzo, N. J. et al. Alzheimer\u2019s therapeutics targeting amyloid Beta 1\u201342 oligomers II: Sigma-2\/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity. PLoS One. 9, e111899 (2014).","journal-title":"PLoS One"},{"key":"87921_CR14","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/jnr.24782","volume":"99","author":"CS Limegrover","year":"2021","unstructured":"Limegrover, C. S. et al. Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson\u2019s patient brain\u2010derived \u03b1\u2010synuclein. J. Neurosci. Res. 99, 1161\u20131176 (2021).","journal-title":"J. Neurosci. Res."},{"key":"87921_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/eye.2015.100","volume":"29","author":"JA Ratnayaka","year":"2015","unstructured":"Ratnayaka, J. A., Serpell, L. C. & Lotery, A. J. Dementia of the eye: the role of amyloid beta in retinal degeneration. Eye (Lond). 29, 1013\u20131026 (2015).","journal-title":"Eye (Lond)"},{"key":"87921_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.exer.2003.10.011","volume":"78","author":"DH Anderson","year":"2004","unstructured":"Anderson, D. H. et al. Characterization of \u03b2 amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp. Eye Res. 78, 243\u2013256 (2004).","journal-title":"Exp. Eye Res."},{"key":"87921_CR17","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1172\/JCI24635","volume":"115","author":"T Yoshida","year":"2005","unstructured":"Yoshida, T. et al. The potential role of amyloid \u03b2 in the pathogenesis of age-related macular degeneration. J. Clin. Invest. 115, 2793\u20132800 (2005).","journal-title":"J. Clin. Invest."},{"key":"87921_CR18","doi-asserted-by":"crossref","unstructured":"Tong, Y. & Wang, S. Not all stressors are equal: mechanism of stressors on RPE Cell Degeneration. Front. Cell. Dev. Biol. 8, (2020).","DOI":"10.3389\/fcell.2020.591067"},{"key":"87921_CR19","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3233\/JAD-171145","volume":"62","author":"RN Martins","year":"2018","unstructured":"Martins, R. N. et al. Alzheimer\u2019s disease: a journey from amyloid peptides and oxidative stress, to Biomarker technologies and Disease Prevention Strategies-gains from AIBL and DIAN Cohort studies. J. Alzheimer\u2019s Dis. 62, 965\u2013992 (2018).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"87921_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4103\/1673-5374.230289","volume":"13","author":"A Medeiros","year":"2018","unstructured":"Medeiros, A., Bubacco, L. & Morgan, J. Impacts of increased \u03b1-synuclein on clathrin-mediated endocytosis at synapses: implications for neurodegenerative diseases. Neural Regen Res. 13, 647\u2013648 (2018).","journal-title":"Neural Regen Res."},{"key":"87921_CR21","doi-asserted-by":"crossref","unstructured":"Liu, Y., Peterson, D. & Schubert, D. Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc. Natl. Acad. Sci. U. S. A. 95, 13266\u201313271 (1998).","DOI":"10.1073\/pnas.95.22.13266"},{"key":"87921_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/15548627.2022.2069437","volume":"19","author":"K Kaarniranta","year":"2023","unstructured":"Kaarniranta, K. et al. Autophagy in age-related macular degeneration. Autophagy 19, 388\u2013400 (2023).","journal-title":"Autophagy"},{"key":"87921_CR23","first-page":"1777","volume":"103","author":"SS Rong","year":"2019","unstructured":"Rong, S. S. et al. Comorbidity of dementia and age-related macular degeneration calls for clinical awareness: a meta-analysis. Br. J. Ophthalmol. 103, 1777\u20131783 (2019).","journal-title":"Br. J. Ophthalmol."},{"key":"87921_CR24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1172\/JCI25843","volume":"116","author":"V Luibl","year":"2006","unstructured":"Luibl, V. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J. Clin. Invest. 116, 378\u2013385 (2006).","journal-title":"J. Clin. Invest."},{"key":"87921_CR25","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1167\/iovs.12-10849","volume":"54","author":"RT Liu","year":"2013","unstructured":"Liu, R. T. et al. Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration. Investig Ophthalmol. Vis. Sci. 54, 2225\u20132237 (2013).","journal-title":"Investig Ophthalmol. Vis. Sci."},{"key":"87921_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/cells10020413","volume":"10","author":"SA Lynn","year":"2021","unstructured":"Lynn, S. A. et al. Oligomeric A\u03b21\u201342 induces an AMD-Like phenotype and accumulates in Lysosomes to impair RPE function. Cells 10, 413 (2021).","journal-title":"Cells"},{"key":"87921_CR27","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4103\/1673-5374.205083","volume":"12","author":"SA Lynn","year":"2017","unstructured":"Lynn, S. A. et al. The complexities underlying age-related macular degeneration: could amyloid beta play an important role? Neural Regen Res. 12, 538\u2013548 (2017).","journal-title":"Neural Regen Res."},{"key":"87921_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mnfr.201800951","volume":"63","author":"E Keeling","year":"2019","unstructured":"Keeling, E. et al. Oxidative stress and dysfunctional intracellular traffic linked to an unhealthy Diet results in impaired Cargo Transport in the retinal pigment epithelium (RPE). Mol. Nutr. Food Res. 63, 1\u201318 (2019).","journal-title":"Mol. Nutr. Food Res."},{"key":"87921_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.preteyeres.2015.09.002","volume":"51","author":"DA Ferrington","year":"2016","unstructured":"Ferrington, D. A., Sinha, D. & Kaarniranta, K. Defects in retinal pigment epithelial cell proteolysis and the pathology associated with age-related macular degeneration. Prog Retin Eye Res. 51, 69\u201389 (2016).","journal-title":"Prog Retin Eye Res."},{"key":"87921_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-642-22107-1_3","volume-title":"Age-related Macular Degeneration","author":"ME Boulton","year":"2013","unstructured":"Boulton, M. E. Ageing of the retina and retinal pigment epithelium. in Age-related Macular Degeneration (eds Holz, F. G., Pauleikhoff, D., Spaide, R. F. & Bird, A. C.) 45\u201363 (Springer Berlin Heidelberg, doi:https:\/\/doi.org\/10.1007\/978-3-642-22107-1_3. (2013)."},{"key":"87921_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/cells7020016","volume":"7","author":"E Keeling","year":"2018","unstructured":"Keeling, E., Lotery, A., Tumbarello, D. & Ratnayaka, J. Impaired Cargo Clearance in the retinal pigment epithelium (RPE) underlies irreversible blinding diseases. Cells 7, 16 (2018).","journal-title":"Cells"},{"key":"87921_CR32","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.4103\/1673-5374.373713","volume":"18","author":"RD Miller","year":"2023","unstructured":"Miller, R. D. & Ratnayaka, J. A. Impaired lysosomes in the retinal pigment epithelium play a central role in the degeneration of the neuroretina. Neural Regen Res. 18, 2697\u20132698 (2023).","journal-title":"Neural Regen Res."},{"key":"87921_CR33","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/alz.12302","volume":"17","author":"NJ Izzo","year":"2021","unstructured":"Izzo, N. J. et al. Preclinical and clinical biomarker studies of CT1812: a novel approach to Alzheimer\u2019s disease modification. Alzheimer\u2019s Dement. 17, 1365\u20131382 (2021).","journal-title":"Alzheimer\u2019s Dement."},{"key":"87921_CR34","doi-asserted-by":"crossref","unstructured":"Lizama, B. N. et al. Sigma-2 receptors\u2014from Basic Biology to Therapeutic Target: a Focus on Age-related degenerative diseases. Int. J. Mol. Sci. 24, (2023).","DOI":"10.3390\/ijms24076251"},{"key":"87921_CR35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ejmech.2019.07.012","volume":"180","author":"D Zampieri","year":"2019","unstructured":"Zampieri, D. et al. Discovery of new potent dual sigma receptor\/GluN2b ligands with antioxidant property as neuroprotective agents. Eur. J. Med. Chem. 180, 268\u2013282 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"87921_CR36","doi-asserted-by":"publisher","first-page":"16845","DOI":"10.1038\/s41598-018-35430-3","volume":"8","author":"A Riad","year":"2018","unstructured":"Riad, A. et al. Sigma-2 Receptor\/TMEM97 and PGRMC-1 increase the rate of internalization of LDL by LDL Receptor through the formation of a Ternary Complex. Sci. Rep. 8, 16845 (2018).","journal-title":"Sci. Rep."},{"key":"87921_CR37","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.1c00048","author":"GM Rishton","year":"2021","unstructured":"Rishton, G. M. et al. Discovery of Investigational Drug CT1812, an antagonist of the Sigma-2 receptor complex for Alzheimer\u2019s Disease. ACS Med. Chem. Lett. Acsmedchemlett. https:\/\/doi.org\/10.1021\/acsmedchemlett.1c00048 (2021). .1c00048.","journal-title":"ACS Med. Chem. Lett. Acsmedchemlett"},{"key":"87921_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00401-023-02679-6","volume":"147","author":"M Colom-Cadena","year":"2024","unstructured":"Colom-Cadena, M. et al. Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer\u2019s disease. Acta Neuropathol. 147, 32 (2024).","journal-title":"Acta Neuropathol."},{"key":"87921_CR39","doi-asserted-by":"publisher","first-page":"106575","DOI":"10.1016\/j.nbd.2024.106575","volume":"199","author":"BN Lizama","year":"2024","unstructured":"Lizama, B. N. et al. An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer\u2019s disease. Neurobiol. Dis. 199, 106575 (2024).","journal-title":"Neurobiol. Dis."},{"key":"87921_CR40","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613 (2019).","journal-title":"Nucleic Acids Res."},{"key":"87921_CR41","doi-asserted-by":"publisher","first-page":"14682","DOI":"10.1073\/pnas.222551899","volume":"99","author":"JW Crabb","year":"2002","unstructured":"Crabb, J. W. et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U S A. 99, 14682\u201314687 (2002).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"87921_CR42","doi-asserted-by":"crossref","unstructured":"Crabb, J. W. The proteomics of drusen. Cold Spring Harb Perspect. Med. 4, (2014).","DOI":"10.1101\/cshperspect.a017194"},{"key":"87921_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","volume":"54","author":"NG Lambert","year":"2016","unstructured":"Lambert, N. G. et al. Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res. 54, 64\u2013102 (2016).","journal-title":"Prog Retin Eye Res."},{"key":"87921_CR44","doi-asserted-by":"publisher","first-page":"e0236283","DOI":"10.1371\/journal.pone.0236283","volume":"15","author":"K Lashkari","year":"2020","unstructured":"Lashkari, K. et al. Plasma biomarkers of the amyloid pathway are associated with geographic atrophy secondary to age-related macular degeneration. PLoS One. 15, e0236283 (2020).","journal-title":"PLoS One"},{"key":"87921_CR45","doi-asserted-by":"crossref","unstructured":"Lynch, A. M. et al. Proteomic profiles in advanced age-related macular degeneration using an aptamer-based proteomic technology. Transl Vis. Sci. Technol. 8, (2019).","DOI":"10.1167\/tvst.8.1.14"},{"key":"87921_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41514-019-0039-5","volume":"6","author":"FM Pool","year":"2020","unstructured":"Pool, F. M., Kiel, C., Serrano, L. & Luthert, P. J. Repository of proposed pathways and protein\u2013protein interaction networks in age-related macular degeneration. Npj Aging Mech. Dis. 6, 1\u201311 (2020).","journal-title":"Npj Aging Mech. Dis."},{"key":"87921_CR47","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1074\/mcp.M900523-MCP200","volume":"9","author":"X Yuan","year":"2010","unstructured":"Yuan, X. et al. Quantitative proteomics: comparison of the macular bruch membrane\/choroid complex from age-related macular degeneration and normal eyes. Mol. Cell. Proteom. 9, 1031\u20131046 (2010).","journal-title":"Mol. Cell. Proteom."},{"key":"87921_CR48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jnr.1247","volume":"66","author":"E Rockenstein","year":"2001","unstructured":"Rockenstein, E., Mallory, M., Mante, M., Sisk, A. & Masliaha, E. Early formation of mature amyloid-\u03b2 protein deposits in a mutant APP transgenic model depends on levels of A\u03b21\u201342. J. Neurosci. Res. 66, 573\u2013582 (2001).","journal-title":"J. Neurosci. Res."},{"key":"87921_CR49","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/JAD-2011-101866","volume":"25","author":"D Havas","year":"2011","unstructured":"Havas, D. et al. A longitudinal study of behavioral deficits in an A\u03b2PP transgenic mouse model of Alzheimer\u2019s disease. J. Alzheimers Dis. 25, 231\u2013243 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"87921_CR50","first-page":"1","volume":"13","author":"U Habiba","year":"2021","unstructured":"Habiba, U. et al. Detection of retinal and blood a\u03b2 oligomers with nanobodies. Alzheimer\u2019s Dement. Diagnosis Assess. Dis. Monit. 13, 1\u201312 (2021).","journal-title":"Alzheimer\u2019s Dement. Diagnosis Assess. Dis. Monit."},{"key":"87921_CR51","doi-asserted-by":"crossref","unstructured":"Booij, J. C. et al. A new strategy to identify and annotate human RPE-specific gene expression. PLoS One 5, (2010).","DOI":"10.1371\/journal.pone.0009341"},{"key":"87921_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/exer.1996.0020","volume":"62","author":"KC Dunn","year":"1996","unstructured":"Dunn, K. C., Aotaki-Keen, A. E., Putkey, F. R. & Hjelmeland, L. M. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 62, 155\u2013169 (1996).","journal-title":"Exp. Eye Res."},{"key":"87921_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.15409.1","volume":"7","author":"SA Lynn","year":"2018","unstructured":"Lynn, S. A. et al. A convenient protocol for establishing a human cell culture model of the outer retina. F1000Research 7, 1\u201327 (2018).","journal-title":"F1000Research"},{"key":"87921_CR54","doi-asserted-by":"publisher","first-page":"7148","DOI":"10.1167\/iovs.10-6374","volume":"52","author":"A Ahmado","year":"2011","unstructured":"Ahmado, A. et al. Induction of differentiation by Pyruvate and DMEM in the human retinal pigment epithelium cell line ARPE-19. Investig. Opthalmol. Vis. Sci. 52, 7148 (2011).","journal-title":"Investig Opthalmology Vis. Sci."},{"key":"87921_CR55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/7651_2019_223","volume":"2150","author":"JA Ratnayaka","year":"2020","unstructured":"Ratnayaka, J. A., Keeling, E. & Chatelet, D. S. Study of Intracellular Cargo trafficking and co-localization in the phagosome and autophagy-lysosomal pathways of retinal pigment epithelium (RPE) cells. Methods Mol. Biol. 2150, 167\u2013182 (2020).","journal-title":"Methods Mol. Biol."},{"key":"87921_CR56","first-page":"60","volume":"23","author":"W Samuel","year":"2017","unstructured":"Samuel, W. et al. Appropriately differentiated ARPE-19 cells regain phenotype and gene expression profiles similar to those of native RPE cells. Mol. Vis. 23, 60\u201389 (2017).","journal-title":"Mol. Vis."},{"key":"87921_CR57","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.exer.2009.12.011","volume":"90","author":"TU Krohne","year":"2010","unstructured":"Krohne, T. U., Stratmann, N. K., Kopitz, J. & Holz, F. G. Effects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells. Exp. Eye Res. 90, 465\u2013471 (2010).","journal-title":"Exp. Eye Res."},{"key":"87921_CR58","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/protein\/gzr020","volume":"24","author":"K Broersen","year":"2011","unstructured":"Broersen, K. et al. A standardized and biocompatible preparation of aggregate-free amyloid beta peptide for biophysical and biological studies of alzheimers disease. Protein Eng. Des. Sel. 24, 743\u2013750 (2011).","journal-title":"Protein Eng. Des. Sel."},{"key":"87921_CR59","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1042\/BJ20110749","volume":"441","author":"V Soura","year":"2012","unstructured":"Soura, V. et al. Visualization of co-localization in A\u03b242-administered neuroblastoma cells reveals lysosome damage and autophagosome accumulation related to cell death. Biochem. J. 441, 579\u2013590 (2012).","journal-title":"Biochem. J."},{"key":"87921_CR60","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0014-4835(87)80105-7","volume":"45","author":"MO Hall","year":"1987","unstructured":"Hall, M. O. & Abrams, T. Kinetic studies of rod outer segment binding and ingestion by cultured rat RPE cells. Exp. Eye Res. 45, 907\u2013922 (1987).","journal-title":"Exp. Eye Res."},{"key":"87921_CR61","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1529\/biophysj.103.038422","volume":"86","author":"SV Costes","year":"2004","unstructured":"Costes, S. V. et al. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J. 86, 3993\u20134003 (2004).","journal-title":"Biophys. J."},{"key":"87921_CR62","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.3390\/ijms21124271","volume":"21","author":"DY Shu","year":"2020","unstructured":"Shu, D. Y., Butcher, E. & Saint-Geniez, M. EMT and EndMT: emerging roles in age-related Macular Degeneration. Int. J. Mol. Sci. 21, 4271 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"87921_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.preteyeres.2014.03.002","volume":"41","author":"IA Pikuleva","year":"2014","unstructured":"Pikuleva, I. A. & Curcio, C. A. Cholesterol in the retina: the best is yet to come. Prog Retin Eye Res. 41, 64\u201389 (2014).","journal-title":"Prog Retin Eye Res."},{"key":"87921_CR64","doi-asserted-by":"publisher","first-page":"8350","DOI":"10.1167\/iovs.12-10495","volume":"53","author":"S Bhattacharya","year":"2012","unstructured":"Bhattacharya, S., Chaum, E., Johnson, D. A. & Johnson, L. R. Age-Related susceptibility to apoptosis in human retinal pigment epithelial cells is triggered by disruption of p53\u2013Mdm2 Association. Invest. Opthalmol. Vis. Sci. 53, 8350 (2012).","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"87921_CR65","doi-asserted-by":"crossref","unstructured":"Sparrow, J. R. Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics. Proc. Natl. Acad. Sci. 113, 4564\u20134569 (2016).","DOI":"10.1073\/pnas.1600474113"},{"key":"87921_CR66","doi-asserted-by":"crossref","unstructured":"Tebbe, L., Kakakhel, M., Al-Ubaidi, M. R. & Naash, M. I. The role of syntaxins in retinal function and health. Front. Cell. Neurosci. 18, (2024).","DOI":"10.3389\/fncel.2024.1380064"},{"key":"87921_CR67","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1074\/mcp.M700571-MCP200","volume":"7","author":"MCM Kwok","year":"2008","unstructured":"Kwok, M. C. M., Holopainen, J. M., Molday, L. L., Foster, L. J. & Molday, R. S. Proteomics of photoreceptor outer segments identifies a subset of SNARE and Rab Proteins Implicated in membrane vesicle trafficking and Fusion. Mol. Cell. Proteom. 7, 1053\u20131066 (2008).","journal-title":"Mol. Cell. Proteom."},{"key":"87921_CR68","doi-asserted-by":"publisher","first-page":"6647","DOI":"10.3390\/ijms21186647","volume":"21","author":"E Keeling","year":"2020","unstructured":"Keeling, E. et al. An In-Vitro Cell Model of Intracellular protein aggregation provides insights into RPE stress Associated with Retinopathy. Int. J. Mol. Sci. 21, 6647 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"87921_CR69","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-023-02548-2","volume":"145","author":"Y Koronyo","year":"2023","unstructured":"Koronyo, Y. et al. Retinal pathological features and proteome signatures of Alzheimer\u2019s disease. Acta Neuropathol. 145, 409\u2013438 (2023).","journal-title":"Acta Neuropathol."},{"key":"87921_CR70","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41419-018-0740-5","volume":"9","author":"A Grimaldi","year":"2018","unstructured":"Grimaldi, A. et al. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer\u2019s disease in the 3xTg-AD mouse model. Cell. Death Dis. 9, 685 (2018).","journal-title":"Cell. Death Dis."},{"key":"87921_CR71","doi-asserted-by":"crossref","unstructured":"Kushwah, N., Bora, K., Maurya, M., Pavlovich, M. C. & Chen, J. Oxidative Stress and Antioxidants in Age-Related Macular Degeneration. Antioxidants 12, (2023).","DOI":"10.3390\/antiox12071379"},{"key":"87921_CR72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield, D. A. & Halliwell, B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat. Rev. Neurosci. 20, 148\u2013160 (2019).","journal-title":"Nat. Rev. Neurosci."},{"key":"87921_CR73","doi-asserted-by":"crossref","unstructured":"Borchert, G. A. et al. The Role of Inflammation in Age-Related Macular Degeneration\u2014Therapeutic Landscapes in Geographic Atrophy. Cells 12, (2023).","DOI":"10.3390\/cells12162092"},{"key":"87921_CR74","unstructured":"Shah, A. & Kishore, U. Complement System in Alzheimer \u2019 s Disease. 1\u201321 (2021)."},{"key":"87921_CR75","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaophthalmol.2022.4602","volume":"141","author":"KL Rasmussen","year":"2023","unstructured":"Rasmussen, K. L., Tybj\u00e6rg-Hansen, A., Nordestgaard, B. G. & Frikke-Schmidt, R. Associations of Alzheimer Disease-Protective APOE variants with age-related Macular Degeneration. JAMA Ophthalmol. 141, 13\u201321 (2023).","journal-title":"JAMA Ophthalmol."},{"key":"87921_CR76","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"87921_CR77","doi-asserted-by":"publisher","unstructured":"Manelli, A. M., Stine, W. B., Van Eldik, L. J. & LaDu, M. J. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function. J. Mol. Neurosci. 23,  235\u2013246. https:\/\/doi.org\/10.1385\/JMN:23:3:235  (2004).","DOI":"10.1385\/JMN:23:3:235"},{"key":"87921_CR78","doi-asserted-by":"crossref","unstructured":"Tai, L. M. et al. Soluble apoE\/A\u03b2 complex: mechanism and therapeutic target for APOE4-induced AD risk. Mol. Neurodegener 9, (2014).","DOI":"10.1186\/1750-1326-9-2"},{"key":"87921_CR79","doi-asserted-by":"publisher","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","volume":"2","author":"D Holtzman","year":"2012","unstructured":"Holtzman, D. & Herz, J. Apolipoprotein E and apolipoprotein receptors: normal biology and roles in Alzheimer\u2019s disease. Cold Spring Harb Perspect. Med. 2, a006312 (2012).","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"87921_CR80","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1750-1326-2-9","volume":"2","author":"JS Gong","year":"2007","unstructured":"Gong, J. S. et al. Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons. Mol. Neurodegener. 2, 9 (2007).","journal-title":"Mol. Neurodegener"},{"key":"87921_CR81","doi-asserted-by":"publisher","first-page":"110078","DOI":"10.1016\/j.cellsig.2021.110078","volume":"86","author":"H Shen","year":"2021","unstructured":"Shen, H. et al. TMEM97 ablation aggravates oxidant-induced retinal degeneration. Cell. Signal. 86, 110078 (2021).","journal-title":"Cell. Signal."},{"key":"87921_CR82","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.3390\/ijms24043417","volume":"24","author":"JH Wang","year":"2023","unstructured":"Wang, J. H. et al. Development of a CRISPRi Human Retinal pigmented epithelium model for functional study of age-related Macular Degeneration genes. Int. J. Mol. Sci. 24, 3417 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"87921_CR83","doi-asserted-by":"crossref","unstructured":"Holz, F. G. et al. Progression of Geographic Atrophy and Impact of Fundus autofluorescence patterns in Age-related Macular Degeneration. Am. J. Ophthalmol. 143, (2007).","DOI":"10.1016\/j.ajo.2006.11.041"},{"key":"87921_CR84","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1080\/15548627.2018.1490851","volume":"14","author":"S Ramachandra Rao","year":"2018","unstructured":"Ramachandra Rao, S. et al. Compromised phagosome maturation underlies RPE pathology in cell culture and whole animal models of Smith-Lemli-Opitz Syndrome. Autophagy 14, 1796\u20131817 (2018).","journal-title":"Autophagy"},{"key":"87921_CR85","doi-asserted-by":"crossref","unstructured":"Storm, T., Burgoyne, T. & Futter, C. E. Membrane trafficking in the retinal pigment epithelium at a glance. J. Cell. Sci. 133, (2020).","DOI":"10.1242\/jcs.238279"},{"key":"87921_CR86","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-023-00358-w","volume":"12","author":"KM LaBarbera","year":"2023","unstructured":"LaBarbera, K. M. et al. A phase 1b randomized clinical trial of CT1812 to measure A\u03b2 oligomer displacement in Alzheimer\u2019s disease using an indwelling CSF catheter. Transl. Neurodegener. 12, 10\u201313 (2023).","journal-title":"Transl. Neurodegener"},{"key":"87921_CR87","doi-asserted-by":"publisher","first-page":"E279","DOI":"10.1073\/pnas.1100901108","volume":"108","author":"JD Ding","year":"2011","unstructured":"Ding, J. D. et al. Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc. Natl. Acad. Sci. U S A. 108, E279\u2013E287 (2011).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"87921_CR88","doi-asserted-by":"crossref","unstructured":"Catchpole, I. et al. Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in Age-Related Macular Degeneration Mouse Model. PLoS One 8, (2013).","DOI":"10.1371\/journal.pone.0065518"},{"key":"87921_CR89","doi-asserted-by":"crossref","unstructured":"Abokyi, S., To, C. H., Lam, T. T. & Tse, D. Y. Central Role of Oxidative Stress in Age-Related Macular Degeneration: Evidence from a Review of the Molecular Mechanisms and Animal Models. Oxid. Med. Cell. Longev. (2020).","DOI":"10.1155\/2020\/7901270"},{"key":"87921_CR90","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.trci.2018.11.001","volume":"5","author":"M Grundman","year":"2019","unstructured":"Grundman, M. et al. A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 5, 20\u201326 (2019).","journal-title":"Alzheimer\u2019s Dement."},{"key":"87921_CR91","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13195-024-01382-2","volume":"16","author":"CH van Dyck","year":"2024","unstructured":"van Dyck, C. H. et al. A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer\u2019s disease. Alzheimers Res. Ther. 16, 20 (2024).","journal-title":"Alzheimers Res. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87921-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87921-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87921-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T05:04:06Z","timestamp":1739163846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87921-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87921"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87921-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BNL, EC, NK, VD, AOC, and MEH are employees of Cognition Therapeutics, Inc. GL is a consultant to Cognition Therapeutics, Inc. EW, EMM, and LW are former employees of Cognition Therapeutics, Inc. BNL, EC, NK, LW, EW, GL, VD, AOC, and MEH are shareholders of Cognition Therapeutics, Inc. All the remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4256"}}